What’s behind Indian pharma cos’ global acquisition spree
India's healthcare firms spent $4.32 billion during January to June of 2022 on mergers and acquisitions, compared to $2.02 billion in the same period last year
marksans pharma company
December 2022
July 2022
Marksans Pharma surges 18% on share buyback plan
The board of Marksans Pharma will meet on July 8 to consider a share buyback proposal.
